Although the measures were designed for use by states and/or health plans, they are being considered for other care settings, such as physician offices.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The seven measures focus on improving medication adherence, appropriateness of therapy and patient outcomes:
1. Adherence to antipsychotics for individuals with schizophrenia.
2. Adherence to mood stabilizers for individuals with bipolar I disorder.
3. Adherence to antiplatelet treatment after stent implantation.
4. Polytherapy with oral antipsychotics.
5. Avoiding acetaminophen toxicity.
6. Short-acting opioid formulation for breakthrough pain in individuals with cancer.
7. Bleeding outcomes related to oral anticoagulants.
Comment on the measures here.
Read the AHA release on CMS seeking comment on medication-related quality measures.
Related Articles on Quality:
Five Months Later, MU Health in Compliance With Federal Patient Safety Standards
UC Regent, Husband Lead the Way to Establishing Prevention Guidelines for Surgical Infections
Connecticut’s Windham Hospital Focuses on Professional Education to Reduce Readmissions
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
